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Abstract
ATP-binding cassette transporters of the subfamily A (ABCA) are responsible for the translocation of lipids including
cholesterol, which is crucial for neurological function. Recent studies suggest that the ABC transporter ABCA7 may play
a role in the development of brain disorders such as schizophrenia and Alzheimer’s disease. However, Abca7’s role in
cognition and other behaviours has not been investigated. Therefore, we characterised homozygous Abca7 knockout mice
in a battery of tests for baseline behaviours (i.e. physical exam, baseline locomotion and anxiety) and behaviours relevant to
schizophrenia (i.e. prepulse inhibition and locomotor response to psychotropic drugs) and Alzheimer’s disease (i.e. cognitive
domains). Knockout mice had normal motor functions and sensory abilities and performed the same as wild type-like
animals in anxiety tasks. Short-term spatial memory and fear-associated learning was also intact in Abca7 knockout mice.
However, male knockout mice exhibited significantly impaired novel object recognition memory. Task acquisition was
unaffected in the cheeseboard task. Female mice exhibited impaired spatial reference memory. This phenomenon was more
pronounced in female Abca7 null mice. Acoustic startle response, sensorimotor gating and baseline locomotion was
unaltered in Abca7 knockout mice. Female knockouts showed a moderately increased motor response to MK-801 than
control mice. In conclusion, Abca7 appears to play only a minor role in behavioural domains with a subtle sex-specific
impact on particular cognitive domains.
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Introduction
ATP-binding cassette (ABC) transporters are classified into
seven subfamilies according to their structure and sequence
homology. The subfamily A (ABCA) is responsible for the
translocation of a variety of lipids including cholesterol across
membranes. There is also evidence to suggest that they might
contribute to regulation of neurogenesis, phagocytosis and host
defense [1–3]. Although the brain is extremely enriched in lipids
little is known about the role that ABCA transporters play in
cognitive function. Emerging evidence indicates that tight
regulation of brain cholesterol homeostasis is crucial for neuro-
logical function and that abnormal cholesterol homeostasis can
contribute to neurodegeneration [4]. Thus, modulation of
endogenous ABCA transporters could potentially have a significant
impact on brain function and susceptibility to neurodegenerative
diseases.
The ABCA transporter ABCA7 is expressed in the mouse brain
with particularly high expression in hippocampal and cortical
neurons as well as microglia [4–6]. A potential role of ABCA7 in
the development of brain disorders has recently been suggested. A
single nucleotide polymorphism (SNP) of ABCA7 has been found
to be associated with schizophrenia [7]. Furthermore, a deregula-
tion of apoptosis in cortical regions of schizophrenia patients has
been reported [8]. Apoptosis is a key process in shaping neuronal
circuits and functions. In this context, ABCA7’s role in phagocy-
tosis [9] might be important to maintain tissue homeostasis and
prevent the release of potentially cytotoxic or antigenic molecules
from dying cells during apoptosis. In Alzheimer’s disease (AD),
common variants in ABCA7 have been linked to AD and a recent
meta-analysis provided compelling evidence that the SNP
rs3764650 represents a new AD susceptibility locus [10].
Furthermore, modulating pathways that regulate cholesterol
homeostasis seem to affect amyloid precursor protein (APP)
processing and the production of b-amyloid peptides, which are
neurotoxic and pro-inflammatory, impair memory and represent
a major constituent of cerebral amyloid plaques associated with
AD [4,11].
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Kim et al. developed a viable homozygous Abca7 knockout
mouse (i.e. Abca72/2) with no remarkable phenotype except
a reduction of white adipose tissue mass in knockout mice and
lower total serum and high-density lipoprotein cholesterol levels in
female Abca72/2 mice [5]. Importantly, the behavioural pheno-
type of this mouse model has not been determined to date.
Therefore, we employed a battery of tests for baseline behaviours
(i.e. physical exam, locomotion in the open field and anxiety in the
elevated plus maze) as suggested by Crawley and others [12,13]
and also considered behaviours relevant to schizophrenia (i.e.
prepulse inhibition and locomotor response to psychotropic drugs
in the open field; [14]) and Alzheimer’s disease (i.e. cognitive
domains using the novel object recognition task, the Y maze, the
fear conditioning paradigm, and the cheeseboard; [15]) in Abca72/
2 mice to explore whether Abca7 influences a broad range of
behavioural domains. This strategy will provide information about
the potential involvement of Abca7 in a variety of behavioural
domains with a particular focus on those relevant to neurodegen-
erative diseases.
Results
Male Abca72/2 mice exhibited wild type-like sensory abilities
and neurological reflexes and showed no differences in motor
abilities or motor function in the accelerod (i.e. latency to fall of
the rotating rod), the pole test (i.e. latency to climb down the pole
to reach platform), the wire hang test (i.e. latency to fall) and the
beam walking test (i.e. latency to cross squared beams) (all p–values
..05; Table 1). The body weight was similar across genotypes
(p..05; Table 1).
Anxiety
In the EPM, locomotive activity (i.e. closed arm distance) and
the occurrence of anxiety-related behaviours (i.e. time in open
arm, open arm entry ratio, and frequency of stretch attend postures)
was similar in WT and Abca72/2 mice (p–values ..05 for all
parameters investigated), indicating that Abca7 deficiency had no
impact on EPM locomotion or anxiety (Table 2). Female mice
showed a somewhat lower level of risk assessment (i.e. frequency of
stretch attend postures) than male mice [two-way ANOVA for ‘sex’:
F(1,38) = 9.6, p= .004; Table 2].
Cognition
Y-maze. Test animals of both genotypes distinguished
between the three arms (‘arm type’: familiar arm 1, familiar arm
2, and novel arm) in the test trial [F(2,80) = 26.7, p,.0001; no
interaction] and developed a preference for the novel arm over the
familiar arms [simple contrasts for arm distance: novel arm versus
familiar arm 1: F(1,40) = 24.0, p,.001– novel arm versus familiar
arm 2: F(1,40) = 49.1, p,.001; Fig. 1]. Short-term memory was
not affected by Abca7 deficiency as novel time [F(1,40) = 3.0,
p..05] and novel distance [F(1,40) = 0.9, p..05] were not
different between genotypes (Table 3).
Table 1. Motor function/coordination in the physical exam and body weight.
Male Female
WT Abca72/2 WT Abca72/2
Accelerod: Latency to fall of rod [s] 149.8615.5 146.5614.0 166.969.5 155.1614.6
Pole test: Latency to reach platform [s] 26.864.5 22.663.9 34.669.7 32.664.1
Wire hang test: Latency to fall [s] 18.562.0 20.363.6 33.164.9 38.364.8
Beam walking test: Latency to cross squared
10 mm2 beam [s]
15.561.2 16.061.6 18.264.1 15.462.2
Beam walking test: Latency to cross squared
5 mm2 beam [s]
13.161.6 12.861.3 13.461.9 12.361.2
Body weight [g] 31.860.5 31.560.8 28.261.1 26.860.8
doi:10.1371/journal.pone.0045959.t001
Table 2. Locomotion and anxiety-related behaviours in the
elevated plus maze.
Male Female
WT Abca72/2 WT Abca72/2
Closed arm distance
[cm]
911.3637.6 849.7648.3 968.9640.8 881.5674.6
Stretch attend postures
[n]
11.061.2 13.561.9 8.160.7## 8.461.5
Open time [s] 19.663.2 18.661.9 15.261.7 15.362.5
Open entry ratio [%] 26.063.1 25.361.7 24.262.2 25.163.8
Distance travelled in enclosed arms, frequency of stretch attend postures, time
spent on open arms (open time) and number of open arm entries as
a percentage of total arm entries (open entry ratio) are shown. Significant one-
way ANOVA split by ‘genotype’ effects of females versus males of the
corresponding genotype are indicated by ‘#’ (##p,.01).
doi:10.1371/journal.pone.0045959.t002
Figure 1. Recognition of familiarity in the Y-maze. Overall arm
distance [cm], in familiar (familiar 1 and familiar 2) and novel arms are
shown.
doi:10.1371/journal.pone.0045959.g001
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Novel object recognition task. Animals distinguished be-
tween the novel and the familiar object presented during the test
trial as indicated by a significant effect of ‘object’ (i.e. novel versus
familiar) on exploration time [F(1,33) = 4.8, p= .04; Table 3].
Importantly, the ability to recognise the novel object was
genotype-dependent [interaction of ‘object’ with ‘genotype’:
F(1,33) = 6.5, p= .02] as only WT mice showed a clear preference
for the novel object [WT: F(1,17) = 14.9; p,.001 - Abca72/2:
F(1,16) = 0.1; p=not significant]. Impaired short-term novel object
recognition memory of Abca7 null mice was confirmed when
analysing the % time mice spent exploring the novel object.
Abca72/2 mice exhibited a reduced level of % novel exploration
[F(1,33) = 7.8, p= .009] with males failing to develop a significant
preference for the novel object (Fig. 2).
Fear conditioning. All animals responded to the electric foot
shocks delivered during the conditioning phase (i.e. vocalization of
all mice). The level of baseline freezing during conditioning (i.e. in
the first 2 min before US presentation) was similar in all mice
regardless of genotype and sex (all p–values ..05; Table 4). As
expected, freezing during the first 2 min of the context test was
significantly increased compared to the first 2 min of freezing in the
conditioning phase regardless of genotype and sex [‘2 min’:
F(1,36) = 39.5, p,.001; no interactions; Table 4]. The ability of
Abca7 knockout mice to associate the context with the US exposure
during conditioning was WT-like, as the total time spent freezing
during the context test was not significantly different across test
groups (all p–values ..05; Table 4). In the cue test, test animals
learned the association between US and CS. Mice responded to
the CS presentation with increased levels of freezing after cue onset
as confirmed by a significant main effect of ‘1 min block’ for time
spent freezing one minute before and one minute post cue
presentation [F(1,36) = 29.8, p,0.001; Fig. 3], indicating associa-
tive learning of WT and Abca72/2 mice.
Cheeseboard. Mice of both sexes and both genotypes
improved their performance to find the food reward over the first
eight days of training, as evidenced by a significant effect of ‘day’
[F(7,273) = 25.3, p,.001]. There was no main effect of ‘genotype’
or ‘sex’ and no interaction on the latency to find the food reward,
demonstrating that all mice equally learned the location of the
reward (Fig. 4A). In the probe trial test, mice showed a preference
for the target zone [t-test for target zone versus other zones:
p= .001]. However, only male mice spent a significantly greater
time in the target zone than chance (i.e. 12.5%) indicating that
they had memorised the location of the food reward [two-way
ANOVA for ‘sex’: F(1,39) = 17.0, p,.001]. Furthermore, a strong
trend for an interaction of ‘sex’ with ‘genotype’ [F(1,39) = 4.0,
p= .05] indicated that the impaired spatial reference memory of
female mice in the probe trial was more pronounced in Abca72/2
females than WT females (Fig. 4B).
Schizophrenia-relevant Behaviours
Startle response and prepulse inhibition. There were no
effects of Abca7 on the startle response of mice (p..05) (Table 5).
Female mice exhibited lower acoustic startle responses to a 120dB
tone than male mice [F(1,39) = 7.0, p= .01]. Startle habituation
over trials occurred in all mice [‘ASR block’: F(2,78) = 8.1,
p= .001] and was similar across genotypes and sex (Fig. 5A).
Prepulse intensities had a significant effect on % PPI [‘prepulse’:
F(2,78) = 137.7, p,.001] with increasing prepulses causing more
pronounced prepulse inhibition. Sensorimotor gating (i.e. % PPI)
was not affected by Abca7 or the sex of the test animals (all p–values
..05; Fig. 5B).
Baseline and MK-801 induced locomotion in the open
field. Mice across genotypes and sex showed similar locomotion
rates (i.e. distance travelled) in the first 30 min of the OF test (all p–
values ..05). Furthermore, all test animals showed habituation of
their locomotive response to the open field in the first drug-free
Table 3. Cognitive performance in the Y-maze (YM) and
novel object recognition task (NORT).
Male Female
YM WT Abca72/2 WT Abca72/2
Novel time [%] 34.762.5 40.865.5 40.762.3 47.964.7




14.962.6 20.963.8 11.862.3 16.263.0
Exploration of novel
object [s]
20.662.7 16.962.0 21.864.7 19.162.8
YM: Time spent in the novel arm (novel time) and distance travelled in the novel
arm (novel distance) as a percentage of the total measure [%] are shown as
measures for short-term memory. NORT: The duration [s] of exploring (time
spent nosing + rearing) the familiar and the novel object are shown as a measure
of working memory.
doi:10.1371/journal.pone.0045959.t003
Figure 2. Novel object recognition. Percentage exploration [%] (i.e.
duration of nosing and rearing) of the novel object (% novel
exploration) is shown for males and females of both genotypes.
Exploration of the novel object according to chance ( = 50%) is marked
with a dotted line. Significant one-way ANOVA effects of Abca72/2
versus WT of the corresponding sex are indicated by ‘*’ (*p,.05).
doi:10.1371/journal.pone.0045959.g002
Figure 3. Fear conditioning in cue test. Time spent freezing [s] for
1 min before (block min: 2) and 1 min post CS onset (block min: 3)
during the cue test is shown.
doi:10.1371/journal.pone.0045959.g003
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30 min of testing [‘5 min block’: F(5,190) = 35.0, p,.001; Fig. 6],
although habituation was influenced by ‘genotype’ and ‘sex’
[interaction of ‘5 min block’ with ‘genotype’ and ‘sex’:
F(5,190) = 3.1, p,.01]. However, this was first of all due to
increased baseline locomotion of WT males in the first 5 min
block compared to Abca72/2 males and all females (Fig. 6).
As expected, MK-801 stimulated locomotion of all test animals
[‘5 min block’ for 90 min OF test session: F(17,646) = 17.5,
p,.001; Fig. 6]. An interaction of ‘5 min block’ with ‘genotype’
[F(17,646) = 1.9, p= .02] was based on increased locomotion levels
of female Abca7 knockout mice in the later test stages [‘5 min
block’ by ‘genotype’ interaction: females: F(17,340) = 17.4, p,.05–
males: not significant].
Discussion
Abca7 null mice have normal sensory abilities, neurological
reflexes and motor functions and show wild type-like anxiety
behaviour and sensorimotor gating. Short-term memory, fear-
associated conditioning and spatial learning were also unaltered in
Abca72/2 mice. However, deficiency in Abca7 disrupted novel
object recognition in male mice. Furthermore, female mice
exhibited disrupted spatial reference memory. This phenomenon
was somewhat more pronounced in Abca72/2 females. Female
Abca72/2 mice also exhibited a moderate longer-lasting response
to the locomotor-stimulating effects of MK-801 treatment than
control females.
Our study expands on the initial finding that Abca7 deficiency
does not result in a remarkable physiological phenotype (i.e.
Table 4. Freezing during conditioning phase and context test.
Male Female
Freezing [s] WT Abca72/2 WT Abca72/2
Conditioning phase
(first 2 min)
4.462.3 1.960.8 0.360.2 0.760.4
Context test (first
2 min)
29.067.6 20.264.5 22.566.3 21.467.3
Context test (total
7 min)
86.3619.2 86.6613.4 93.3618.2 94.6617.9
Time spent freezing [s] is shown.
doi:10.1371/journal.pone.0045959.t004
Figure 4. A+B Cheeseboard: A) Mean latency (averaged across three trials per day) to find the food reward [s] and B) percentage
time [%] spent in the target zone during the probe trial (% target zone time). Time spent in the zone according to chance ( = 12.5%) is
marked with a dotted line. There was a strong trend for an interaction of ‘sex’ with ‘genotype’ interaction in the probe trial (p= .05). Significant one-
way ANOVA effects of females versus males of the corresponding genotype are indicated by ‘#’ (###p,.001).
doi:10.1371/journal.pone.0045959.g004
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unaltered food consumption, body weight development and
weight of major organs; [5]), as our baseline tests revealed normal
neurophysiological functioning of Abca7 null mice and no gross
behavioural abnormalities in locomotion, exploration and anxiety.
We investigated the cognitive phenotype of Abca7 null mice as
human research has linked common variants in ABCA7 to AD
[10]. The test battery incorporated tests for short-term memory of
context familiarity (Y-maze), object recognition, amygdalar and
Figure 5. A+B: Habituation of startle response and sensorimotor gating: A) Habituation of the acoustic startle response to a tone
stimulus of 120dB [millivolts] and B) % PPI for different prepulse intensities [%].
doi:10.1371/journal.pone.0045959.g005
Table 5. Acoustic startle response to a 120 dB startle stimulus
during PPI testing.
Male Female
PPI WT Abca72/2 WT Abca72/2
Acoustic startle
response
110.2618.3 114.7611.4 69.568.4 88.6610.9
Acoustic startle response [millivolts] is shown.
doi:10.1371/journal.pone.0045959.t005
Figure 6. Baseline and MK-801 induced locomotion in the open
field. Overall distance travelled [cm] (in 5 min blocks) in the open field
in a 90 min session where animals received an i.p. injection of MK-801
(0.25 mg/kg body weight) after 30 min of baseline testing (indicated by
black arrow). There was an interaction of ‘5 min block’ with ‘genotype’
in females (p,.05).
doi:10.1371/journal.pone.0045959.g006
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hippocampal associative learning and spatial reference memory.
Abca72/2 mice exhibited a task- and moderate sex-specific
impairment of cognitive abilities. Male Abca7 null mice showed
disrupted object recognition (a better performance of females in
a visual memory task has also been shown in other studies and has
been related to sex hormones [16,17]). Female knockout mice on
the other side exhibited impaired spatial reference memory. It has
been found that male rats perform better in reference memory,
when it has been differentiated from the working memory aspects
of a paradigm [18] and mouse studies have discussed reduced
reference memory of females in relation to eostradiol levels
[19,20]. The cognitive impairments of Abca7 deficient mice are in
line with the expression profile of ABCA7, which is abundant in
hippocampal and cortical neurons [5,6], suggesting a potential
moderate role of the ABC transporter in cognitive domains.
Importantly, the impact of Abca7 on cognition cannot be
generalised across different ABC transporters: for example, the
Abcg1 transporter is not involved in cognitive functioning as mice
selectively overexpressing Abcg1 performed equivalently to their
WT littermates in the spatial reference and working memory
version of the Morris water maze [21], which is a paradigm similar
to the cheeseboard test [22].
Interestingly, validated mouse models for familial AD have
shown disrupted spatial reference memory and object recognition
[23–25] and deficiency in Abca1, which is one of the main ABC
transporters and essential for cholesterol homeostasis, exacerbated
amyloidogenesis in amyloid mouse models of AD [26,27], whereas
Abca1 overexpression ameliorated amyloid load [28]. Another
study reported that agonists of liver X receptors reduce Ab levels
and improve cognition in AD mice but only in the presence of
ABCA1 [29]. As ABCA7 has the highest homology of all ABC
transporters to ABCA1, it appears logical to investigate Abca7’s
role in amyloid pathology as well. Indeed, our earlier in vitro work
found that ABCA7 stimulates cholesterol efflux to apoE discs,
regulates processing of amyloid precursor protein and inhibits the
generation of neurotoxic Ab peptides [11]. Future research should
focus on the role that Abca7 may play in cognition in established
mouse models for AD.
A SNP of ABCA7 has been found to be associated with
schizophrenia [7] and ABCA7’s role in phagocytosis might impact
on the deregulation of apoptosis in cortical regions of schizophre-
nia patients [8,9]. The defects in the apoptotic pathway of
schizophrenia patients may be a factor contributing to dysfunc-
tional autoimmune system and elevated inflammatory cytokines
observed in these patients [7]. Thus, we tested Abca7 null mice in
behavioural tasks relevant to schizophrenia: Abca7 deficient mice
showed unaltered baseline locomotion and sensorimotor gating
but female Abca72/2 appeared to have longer-lasting susceptibility
to the locomotion-stimulating effects of acute MK-801 treatment,
which might indicate changes to the glutamatergic system, the
processing of MK-801, or more specifically the NMDA receptor
sensitivity/expression levels. Sexually dimorphic effects of MK-
801 have been described by colleagues in the past [30].
Importantly, changes to the glutamatergic system are in line with
the hypoglutamatergic hypothesis of schizophrenia [31].
The moderate behavioural differences detected between male
and female Abca72/2 mice are consistent with sex-dependent
effects of ABCA7 on mouse physiology (i.e. less visceral fat, lower
serum and high-density lipoprotein cholesterol levels in female but
not male knockouts [5]).
At this present stage the exact function of ABCA7 is not fully
defined. The initial identification of ABCA7 in hemopoietic cells
pointed towards a role for regulating macrophage lipid efflux in
particular [32]. Furthermore, given the homology of ABCA7 with
ABCA1 it was predicted that ABCA7 would mediate cholesterol
efflux. Most studies have confirmed that ABCA7 mediates
phospholipid efflux, however ABCA7 is not as effective at
mediating cholesterol efflux [33,34]. In contrast to this expecta-
tion, macrophages isolated from Abca72/2 mice exhibited normal
cholesterol and phospholipid efflux thereby indicating that
ABCA7 may have another distinct biological function [5]. More
recent work identified a role for ABCA7 in host defence system
[35,36]. The available evidence suggests that macrophage ABCA7
plays a key role in phagocytosis of apoptotic debris [36]. Because
microglia actively phagocytose apoptotic debris in the brain [37],
and data from our own laboratory indicates that ABCA7 has the
highest expression in human microglia [6], a function for
microglial ABCA7 in phagocytosis of apoptotic debris is also
plausible. Unrelated to the lipid efflux activity, ABCA7 may
modulate APP processing by altering the trafficking of APP with
low-density lipoprotein receptor-related protein to the cell surface
[36]. Furthermore, two splice variants of ABCA7 detected in the
human brain in one study may have different biological functions
[38]. The so-called type II ABCA7 isoform appears to be localised
in the endoplasmic reticulum, unlike the major isoform, which is
predominantly localised to the plasma membrane.
Based on the high level of homology between ABCA7 and
ABCA1, published data on behavioural effects of Abca1 deficiency
may shed more light on the impact of ABC transporters on
behavioural domains and the potential mechanisms. Cholesterol
homeostasis changes in Cre-lox Abca1 mutant mice were mirrored
by disturbances to motor activity and improved sensorimotor
gating [39]. However, Cre-lox mice showed normal cognitive
abilities in the Morris water maze. Thus, the behavioural
phenotype of Abca72/2 mice appears quite different to what has
been described for Abca12/2 mice. Importantly, in vitro work
confirms that ABCA7 does not recapitulate ABCA1 function but
rather has distinct activities on apolipoprotein-derived generation
of high-density lipoprotein [40] and cellular phagocytotic function
[9]. Furthermore, Abca7 null mice have no defect in apolipopro-
tein-stimulated sterol or phosphatidylcholine transport, suggesting
that cholesterol and phosphatidylcholine are not likely to be the
primary physiological substrates of ABCA7 transporter activity
[5].
In conclusion, this study is the first to provide a detailed analysis
of Abca7 function in behavioural domains relevant to neurode-
generative diseases in vivo. Abca7 appears to impact on particular
aspects of cognitive functioning and to have a subtle effect on the
locomotor response to NMDA blockage. Further research will
clarify, if therapeutic strategies targeting ABCA7 might be
beneficial in improving cognitive functioning in AD.
Materials and Methods
Animals
The generation of Abca7 null (Abca72/2) mice, which were
generously provided by Prof. Mason W. Freeman (Centre for
Computational and Integrative Biology, Massachusetts General
Hospital, Harvard Medical School), has been described elsewhere
[5]. Test mice were adult (males: 1963 weeks; females: 2064
weeks) cohorts of male and female Abca72/2 mice and wild type-
like control littermates (WT), which had been backcrossed for 15
generations onto a C57BL6/J background (males: Abca72/2=11
and WT=10; females: Abca72/2=8 and WT=15). Mice were
bred and housed in independently ventilated cages (Airlaw,
Smithfield, Australia) at Animal BioResources (Moss Vale,
Australia). Two weeks before testing mice were transported to
Neuroscience Research Australia (NeuRA), where they were pair-
Abca7’s Impact on Mouse Behaviour
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housed in Polysulfone cages (1144B: Tecniplast, Rydalmere,
Australia), which were enriched with certified polycarbonate
mouse igloo (Bioserv, Frenchtown, USA), tissues for nesting
material and a steel ring in the cage lid. Mice were kept pair-
housed under a 12: 12 h light: dark schedule [light phase: white
light (illumination: 124 l6) – dark phase: red light (illumination:
,2 l6)]. Food and water were available ad libitum.
Ethics statement. Research and animal care procedures
were approved by the University of New South Wales Animal
Care and Ethics Committee in accordance with the Australian
Code of Practice for the Care and Use of Animals for Scientific
Purposes.
Behavioural Phenotyping
Animals were tested in a battery of behavioural tasks relevant to
schizophrenia and cognition, which are well-established at
Neuroscience Research Australia (the least aversive/disruptive
tasks were carried out first) [15,41,42]: elevated plus maze, Y
maze, novel object recognition task, fear conditioning, prepulse
inhibition, open field [baseline and after treatment with non-
competitive N-methyl-D-aspartate (NMDA) antagonist MK-801]
and cheeseboard using an inter-test interval of at least six days. All
devices (and objects) were cleaned thoroughly with 70% ethanol in
between trials and sessions. All testing occurred during the light
phase (within 1–5 h of light onset) with the exemption of the
elevated plus maze, which was run during the dark phase (2 h
prior to light onset). An additional male cohort (N: Abca72/2=6
and WT=6) was tested for motor functions and coordination as
well as sensory abilities to avoid that impairments in those domains
result in false positive or negative phenotyping outcomes [12,43].
Elevated plus maze (EPM). Mice were allowed to explore
the apparatus freely for 5 min (as described previously [43]). Arm
entries (when the mouse entered an arm with all four paws),
distance travelled, time spent in arms as well as the frequency of
rearing, and head dipping were scored for the different arms. Anxiety-
related behaviour was measured by time spent on open arms (open
time) and open arm entries as a percentage of the total measures
(open entry ratio), and the frequency of stretch attend postures.
Y-maze (YM). The Y-maze assessed short-term memory of
context familiarity [44]. Arms were equipped with different
internal visual cues. Bedding covered the apparatus floor and
was changed in between sessions. The Y-maze test consisted of two
trials with a 30 min inter-trial interval (ITI). The trial duration for
training and test was 10 and 5 min respectively. During training,
one arm was blocked off (novel arm). In the test trial, all arms were
accessible, and mice were allowed to explore the apparatus freely.
Time spent and distance travelled was recorded for each arm using
Any-MazeTM video tracking software (Stoelting Co., Wood Dale,
USA). The percentage of time spent in the novel arm (novel time)
was calculated using [(novel time/total time) 6 100]. The
corresponding calculation was performed for distance travelled
in the novel arm (novel distance).
Novel object recognition task (NORT). The distinction
between familiar and unfamiliar objects is an index of recognition
memory, and its measurement is aided by the innate preference of
rodents for novel over familiar objects [45]. The NORT was
conducted over 3 days; two trials (10 min per trial) were conducted
per day with a 1 h ITI (for details see [15,41,42]). On the test day
(following two days of habituation to the arena and the test
procedure), mice were exposed to two identical objects in trial 1
(sample trial), and then one familiar and one novel object in trial 2
(test trial). Objects and their location were counterbalanced across
genotypes. The frequency and duration of nosing and rearing the
familiar and novel objects were recorded offline by a trained
experimenter blind to the sex and genotype of the test animals
using Any-MazeTM tracking software. The percentage exploration
time (time spent nosing + rearing objects) for the novel object (%
novel exploration) was calculated using [(novel object exploration
time/novel + familiar object exploration time)6100] and served
as an indicator for short-term object recognition memory.
Fear conditioning (FC). Fear conditioning (FC) is a form of
associative learning that occurs when a previously neutral stimulus
(e.g. tone) elicits a fear response after it has been paired with an
aversive stimulus [46]. On conditioning day, animals were placed
in the test chamber (Model H10-11R-TC, Coulbourn Instru-
ments, Whitehall, USA) for 120 s. A 80 dB conditioned stimulus
(CS) was presented for 30 s with a co-terminating 0.4 mA 2 s foot
shock (unconditioned stimulus; US) twice with an inter-pairing
interval of 120 s. The test concluded 120 s later. On day 2 (context
test), the animals were returned to the apparatus for 7 min. On
day 3 (cue test), animals were placed in an altered context for
9 min. After 120 s (pre-CS/baseline), the CS was presented
continuously for 5 min. The test concluded after another 120 s
without the CS. Time spent freezing was measured using Any-
MazeTM software [15,41,42].
Prepulse inhibition (PPI). PPI is an operational measure of
sensorimotor gating, which is impaired in schizophrenia patients
[47,48]. Startle reactivity was measured in millivolts using SR-
LAB startle chambers (San Diego Instruments, San Diego, USA).
The PPI test consisted of 5 min acclimatisation to 70 dB
background noise, followed by 121 trials in a pseudorandom
order: 5670 dB trials (background); 5690 dB trials; 156120 dB
trials (startle) and 96 trials comprising a prepulse of either 74, 82 or
86 dB presented 32, 64, 128, or 256 ms (variable interstimulus
interval; ISI) prior to a startling pulse of 120 dB (PPI response) (for
further details see [49]). The blocks of startle responses at the
beginning, middle and end of the PPI protocol (averaged across 5
trials each) were used for ASR habituation. Percentage PPI (%
PPI) was calculated as [(mean startle response – PPI response)/
mean startle response]6100. % PPI was averaged across ISIs to
produce a mean % PPI for each prepulse intensity.
Open field (OF). General motor activity was evaluated by
placing the mouse into an infrared photobeam controlled open
field activity chambers (41 cm 6 41 cm; Tru-Scan Photo Beam
Activity System: Coulbourn Instruments). Animals were tested for
30 min (baseline) before MK-801 (0.25 mg/kg body weight;
dissolved in saline) was administered i.p. (injection volume:
10 ml/kg body weight). Following the injection, animals were
put back into the OF chambers for another 60 min (MK
treatment). Distance travelled and rearing were measured using
Any-MazeTM software [15,41,42].
Cheeseboard (CB). The cheeseboard (CB) paradigm was
employed as a dry-land equivalent of the Morris water maze
[15,22,50]. Mice were trained to find a food reward over a number
of days; reference memory was indexed by a decreased latency to
find the reward over days. During habituation (three days to the
blank side of the CB) two 2 min trials were conducted each day
with a 10 min ITI. Mice were food-restricted (starting 24 h before
the first habituation session) and kept at 85–90% of their pre-test
body weight throughout testing (mice were fed for 1–2 h per day).
Task Acquisition/Spatial Reference Memory Training: Mice were trained
over 15 days (three trials per day with a 10 min ITI) to locate the
food reward. The location of the target well (counterbalanced
across genotypes) was kept constant for each mouse between trials
and across days. If the target well was not located within 2 min,
mice were placed next to the target well and allowed to consume
the food reward. Spatial Reference Memory: A probe trial was
conducted on day 9 (males and females) and day 16 (males only),
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where no wells were baited and mice were given 2 min to explore
the board freely (probe trial 16 results are shown for males as no
clear target preference was detected on day 9). For this, the board
was divided into 8 zones corresponding to each line of 4 caps as
well as a centre zone (40 cm diameter = start zone). The time spent
in each zone was measured using Any-MazeTM. Data are
presented for ‘% target zone time’, which calculates the time
spent in the target zone as a percentage of time spent in all zones
(minus the time spent in the start zone).
Statistical Analysis
Results were analysed using two-way analysis of variance
(ANOVA: between factor: ‘genotype’ and ‘sex’) followed by one-
way ANOVA split by corresponding factor(s) where appropriate as
published previously [51,52]. Three-way repeated measures (RM)
ANOVAs were used to control for successful learning (Y-maze:
‘arm type’, NORT: ‘object’), for effects across trial types (FC: ‘first
2 min’, CB: ‘day’, PPI: ‘ASR block’ and ‘prepulse’), or for effects
over time (OF: ‘5 min block’, FC: ‘1 min block’), which were
followed by simple contrasts where appropriate. For the cheese-
board probe trials, single sample t-tests were used to assess if %
target zone time was greater than chance (i.e. 12.5%). The
physical exam data were analysed using one-way ANOVAs
(between factor: ‘genotype’). Analyses were conducted using SPSS
for Windows 19.0. Differences were regarded as significant if
p,.05. In line with Rothman and Perneger the data were not
adjusted for multiple comparisons and were interpreted as such in
the discussion [53,54]. All data are presented as means6 standard
error of the mean (SEM). Significant one-way ANOVA effects of
Abca72/2 versus WT of the corresponding sex are indicated by ‘*’
(*p,.05, **p,.01 and ***p,.001) and significant effects of females
versus males of the corresponding genotype are indicated by ‘#’
(#p,.05, ##p,.01 and ###p,.001).
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